Overall, these results indicate the crucial role of immunity in the development of NAFLD, and suggest that POLD1 may play an essential role in the immune microenvironment of NAFLD patients. The gene discussed is POLD1; the disease is metabolic dysfunction-associated steatotic liver disease.